Company News

LTS and Revive Therapeutics enter into Feasibility Agreement to develop Oral Psilocybin Thin Film Strip

LTS and Revive Therapeutics Ltd. are pleased to announce that they have entered into a feasibility agreement to develop and manufacture a proprietary oral psilocybin thin film strip for the Company’s clinical and commercial initiatives to evaluate in mental illness, neurological and substance abuse disorders.

2021-05-17T17:26:02+02:0017.05.2021|Kategorie(n): Company News|
Go to Top